Nexium IV Approved for Gastroesophageal Reflux Disease (GERD)
Nexium IV (esomeprazole sodium) is a new administration formulation for the prescription proton pump inhibitor Nexium. Nexium IV is approved as an intravenous infusion or injection for the short-term treatment (up to 10 days) of gastroesophageal reflux disease (GERD) patients, with a history of erosive esophagitis, who are unable to take capsules.Related Articles:
FDA Approves Nexium for Use in Children Ages 1-11 Years - February 28, 2008
FDA Approves Nexium for the Treatment of Zollinger-Ellison Syndrome - October 12, 2006
Nexium Approved for Children 12 to 17 For Short-Term Treatment of GERD - May 1, 2006
Nexium approved for reduced risk of stomach ulcer development among NSAID users - November 29, 2004
FDA Approves Nexium for Erosive Esophagitis, Gastroesophageal Reflux Disease and Prevention of Duodenal Ulcers - February 20, 2001
FDA Drug Approvals Archive
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Aug | Oct | Dec
